MedWatch

Co-founder and CEO wants to replace himself

A Danish medtech company, which secured millions in extra funding in February, is looking for a new CEO. The current CEO, who is also co-founder and shareholder, is set to leave the company, which is closing in on commercialisation.

Foto: Colourbox

In the spring of 2014, Danish medtech company, Acarix, will launch a long-awaited product that has come to be known as the “blood clot alarm”. The initial plan is to market the product and generate solid sales in 3-4 European markets. A possible exit will not be on the cards until that has been achieved, explains Peter Samuelsen, co-founder and CEO in Acarix, in an interview with Medwatch.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier